8-K/A

AMENDMENT TO CURRENT REPORT

Company: REGENERON PHARMACEUTICALS, INC.
Filed: September 15, 2011
Period of Report: September 15, 2011
Accession Number: 0001206774-11-002065

View Document ↗ View on SEC.gov ↗